CHEBI:37890 - α-adrenergic antagonist

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name α-adrenergic antagonist
ChEBI ID CHEBI:37890
ChEBI ASCII Name alpha-adrenergic antagonist
Definition An agent that binds to but does not activate α-adrenergic receptors thereby blocking the actions of endogenous or exogenous α-adrenergic agonists. α-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
Stars This entity has been manually annotated by the ChEBI Team.
ChEBI Ontology
Outgoing α-adrenergic antagonist (CHEBI:37890) is a α-adrenergic drug (CHEBI:48539)
α-adrenergic antagonist (CHEBI:37890) is a adrenergic antagonist (CHEBI:37887)
Incoming 2-methoxyidazoxan (CHEBI:73287) has role α-adrenergic antagonist (CHEBI:37890)
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine (CHEBI:64098) has role α-adrenergic antagonist (CHEBI:37890)
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine hydrochloride (CHEBI:64094) has role α-adrenergic antagonist (CHEBI:37890)
N-demethylmirtazapine (CHEBI:143428) has role α-adrenergic antagonist (CHEBI:37890)
rac-tamsulosin (CHEBI:142552) has role α-adrenergic antagonist (CHEBI:37890)
rac-tamsulosin hydrochloride (CHEBI:142565) has role α-adrenergic antagonist (CHEBI:37890)
ajmalicine (CHEBI:2524) has role α-adrenergic antagonist (CHEBI:37890)
alfuzosin (CHEBI:51141) has role α-adrenergic antagonist (CHEBI:37890)
asenapine (CHEBI:71253) has role α-adrenergic antagonist (CHEBI:37890)
asenapine maleate (CHEBI:71245) has role α-adrenergic antagonist (CHEBI:37890)
carvedilol (CHEBI:3441) has role α-adrenergic antagonist (CHEBI:37890)
cleistanthin A (CHEBI:3737) has role α-adrenergic antagonist (CHEBI:37890)
cleistanthin B (CHEBI:84407) has role α-adrenergic antagonist (CHEBI:37890)
clopenthixol (CHEBI:59115) has role α-adrenergic antagonist (CHEBI:37890)
dapiprazole (CHEBI:51066) has role α-adrenergic antagonist (CHEBI:37890)
desipramine (CHEBI:47781) has role α-adrenergic antagonist (CHEBI:37890)
dihydroergocristine mesylate (CHEBI:31490) has role α-adrenergic antagonist (CHEBI:37890)
doxazosin (CHEBI:4708) has role α-adrenergic antagonist (CHEBI:37890)
ergoloid mesylate (CHEBI:34706) has role α-adrenergic antagonist (CHEBI:37890)
flupenthixol (CHEBI:5121) has role α-adrenergic antagonist (CHEBI:37890)
idazoxan (CHEBI:5862) has role α-adrenergic antagonist (CHEBI:37890)
ketanserin (CHEBI:6123) has role α-adrenergic antagonist (CHEBI:37890)
labetalol (CHEBI:6343) has role α-adrenergic antagonist (CHEBI:37890)
mianserin (CHEBI:51137) has role α-adrenergic antagonist (CHEBI:37890)
mirtazapine (CHEBI:6950) has role α-adrenergic antagonist (CHEBI:37890)
nefazodone (CHEBI:7494) has role α-adrenergic antagonist (CHEBI:37890)
paliperidone (CHEBI:82978) has role α-adrenergic antagonist (CHEBI:37890)
paliperidone palmitate (CHEBI:83807) has role α-adrenergic antagonist (CHEBI:37890)
phentolamine (CHEBI:8081) has role α-adrenergic antagonist (CHEBI:37890)
prazosin (CHEBI:8364) has role α-adrenergic antagonist (CHEBI:37890)
prochlorperazine (CHEBI:8435) has role α-adrenergic antagonist (CHEBI:37890)
quinidine (CHEBI:28593) has role α-adrenergic antagonist (CHEBI:37890)
risperidone (CHEBI:8871) has role α-adrenergic antagonist (CHEBI:37890)
roxindole (CHEBI:48558) has role α-adrenergic antagonist (CHEBI:37890)
sertindole (CHEBI:9122) has role α-adrenergic antagonist (CHEBI:37890)
spiperone (CHEBI:9233) has role α-adrenergic antagonist (CHEBI:37890)
tamsulosin (CHEBI:9398) has role α-adrenergic antagonist (CHEBI:37890)
tamsulosin hydrochloride (CHEBI:9399) has role α-adrenergic antagonist (CHEBI:37890)
terazosin (CHEBI:9445) has role α-adrenergic antagonist (CHEBI:37890)
thioridazine (CHEBI:9566) has role α-adrenergic antagonist (CHEBI:37890)
tolazoline (CHEBI:28502) has role α-adrenergic antagonist (CHEBI:37890)
yohimbine (CHEBI:10093) has role α-adrenergic antagonist (CHEBI:37890)
zuclopenthixol (CHEBI:51364) has role α-adrenergic antagonist (CHEBI:37890)
Synonyms Sources
α-adrenergic antagonists ChEBI
α-adrenergic blocker ChEBI
α-adrenergic blockers ChEBI
α-adrenergic receptor blockaders ChEBI
α-adrenoceptor antagonists IUPHAR
Last Modified
03 June 2019